Stay updated on Pediatric Fevipiprant Chewable Tablet Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fevipiprant Chewable Tablet Clinical Trial page.

Latest updates to the Pediatric Fevipiprant Chewable Tablet Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study on the pharmacokinetics of fevipiprant in pediatric asthma has undergone significant revisions, including the discontinuation of the study due to previous analyses not meeting clinically relevant thresholds. Additionally, the study now includes two treatment dose cohorts and updated age stratification for participants.SummaryDifference27%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoNo Change Detected
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Pediatric Fevipiprant Chewable Tablet Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fevipiprant Chewable Tablet Clinical Trial page.